Gross Margin

Newly public Yesway faces its first major test with its Q1 earnings. Investors will scrutinize if its aggressive expansion can meet high analyst expectations.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Hesai Group posts another profitable quarter and a major Mercedes-Benz deal, while unveiling a strategic pivot from hardware to a 'Physical AI' ecosystem.

Nearly 40% of skin care sales will be online by 2030, powered by AI. Discover how algorithms are the new beauty counter and what it means for you.

EMS, backed by Wynnchurch Capital, acquires a key rival, signaling a strategic consolidation push in the booming U.S. aluminum distribution market.

Record heat and soaring energy costs are straining wallets. New 'drop-in' heat pumps offer an affordable, high-efficiency upgrade without a major renovation.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Amid tourism recovery and new delivery laws, NUGL reports strong Q1 earnings, signaling a new era for Jamaica's burgeoning regulated cannabis industry.

Alarum Technologies will report Q1 results on May 28. Investors are watching to see if massive AI investments are fueling sustainable growth or just costs.

The footwear giant exceeded Q1 expectations, boosting its full-year profit outlook on the back of double-digit growth from its star athletic brands.

With 799% revenue growth and major Fortune 10 deals, Energous proves wireless power is no longer a gadget gimmick but essential industrial tech.

The 2026 Chandler Index reveals a paradox: government performance is up, but a staggering 70% of nations are fiscally weaker than five years ago.

With strong HIFU revenue and new clinical trials, EDAP TMS's upcoming Investor Day will reveal its strategy for medtech dominance and investor confidence.

As the space economy booms, a top TMT research firm launches dedicated coverage, signaling a new era of financial scrutiny for giants like SpaceX and Rocket Lab.

AutoCanada posts a Q1 loss amid a soft market, accelerating its U.S. dealership sale and relying on new leadership and its collision arm for recovery.

A new six-month semaglutide implant is entering clinical trials, aiming to solve the adherence crisis plaguing GLP-1 drugs like Ozempic and Wegovy.

How a 125-year-old family flour mill earned Gold Honoree status by blending heritage with high-tech innovation and sustainable food solutions.

A new report reveals a record 4,434 satellites launched in 2025, as the industry's revenue soars and U.S. innovation solidifies its global dominance.

Sony unleashes the FE 100-400mm F4.5 GM OSS, a pricey super-telephoto with a constant aperture and blazing AF aimed at pro sports and wildlife shooters.

The luggage giant reports a 4.1% revenue increase and a major cash flow turnaround, while advancing plans for a strategic US stock market debut this year.